| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 1.000 | |
| chromatin organization | GO:0006325 | 351 | 1.000 | |
| chromatin modification | GO:0016568 | 298 | 1.000 | |
| covalent chromatin modification | GO:0016569 | 254 | 1.000 | |
| regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter | GO:0072366 | 1 | 1.000 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 1.000 | Human |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 1.000 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 1.000 | |
| vasculature development | GO:0001944 | 181 | 1.000 | |
| positive regulation of erythrocyte differentiation | GO:0045648 | 11 | 1.000 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 3 | 1.000 | |
| negative regulation of transcription initiation from rna polymerase ii promoter | GO:0060633 | 3 | 1.000 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 1.000 | |
| nervous system development | GO:0007399 | 293 | 1.000 | |
| response to peptide | GO:1901652 | 65 | 1.000 | |
| negative regulation of developmental process | GO:0051093 | 247 | 1.000 | Mouse |
| response to cytokine | GO:0034097 | 232 | 1.000 | Rat |
| response to hormone | GO:0009725 | 175 | 1.000 | Human |
| response to abiotic stimulus | GO:0009628 | 336 | 1.000 | Human |
| circulatory system development | GO:0072359 | 262 | 1.000 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 1.000 | |
| wnt signaling pathway | GO:0016055 | 156 | 1.000 | |
| blood vessel development | GO:0001568 | 172 | 1.000 | |
| intracellular estrogen receptor signaling pathway | GO:0030520 | 23 | 1.000 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 1.000 | Human |
| cellular response to nitrogen compound | GO:1901699 | 144 | 1.000 | |
| histone modification | GO:0016570 | 251 | 1.000 | |
| carbon catabolite activation of transcription | GO:0045991 | 3 | 1.000 | |
| positive regulation of cell death | GO:0010942 | 263 | 1.000 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 1.000 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 3 | 1.000 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 1.000 | Human |
| chemical homeostasis | GO:0048878 | 306 | 1.000 | |
| neuron differentiation | GO:0030182 | 138 | 1.000 | |
| muscle structure development | GO:0061061 | 98 | 1.000 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 1.000 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 1.000 | |
| protein acetylation | GO:0006473 | 116 | 1.000 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 1.000 | |
| histone acetylation | GO:0016573 | 93 | 1.000 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 1.000 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 1.000 | |
| response to insulin | GO:0032868 | 45 | 1.000 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 1.000 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.999 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.999 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.999 | |
| erythrocyte homeostasis | GO:0034101 | 31 | 0.999 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.999 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.999 | Human |
| response to organonitrogen compound | GO:0010243 | 156 | 0.999 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.999 | Human |
| positive regulation of feeding behavior | GO:2000253 | 1 | 0.999 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.999 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.999 | |
| circadian behavior | GO:0048512 | 2 | 0.999 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.999 | |
| cellular response to insulin stimulus | GO:0032869 | 41 | 0.999 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.999 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.999 | |
| histone h4 acetylation | GO:0043967 | 47 | 0.999 | Human |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.999 | |
| dna templated transcription initiation | GO:0006352 | 35 | 0.998 | |
| histone h3 acetylation | GO:0043966 | 45 | 0.998 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.998 | |
| regulation of erythrocyte differentiation | GO:0045646 | 17 | 0.998 | |
| monosaccharide metabolic process | GO:0005996 | 74 | 0.998 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.998 | Mouse |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.998 | Human |
| positive regulation of glucocorticoid receptor signaling pathway | GO:2000324 | 1 | 0.998 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.998 | |
| angiogenesis | GO:0001525 | 147 | 0.998 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.998 | |
| oogenesis | GO:0048477 | 2 | 0.998 | Worm |
| hexose metabolic process | GO:0019318 | 55 | 0.997 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 54 | 0.997 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.997 | |
| regulation of intracellular steroid hormone receptor signaling pathway | GO:0033143 | 32 | 0.997 | Human |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.997 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.997 | |
| cell morphogenesis | GO:0000902 | 296 | 0.997 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.997 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.997 | |
| pharynx development | GO:0060465 | 1 | 0.997 | |
| organ morphogenesis | GO:0009887 | 147 | 0.997 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.997 | |
| protein acylation | GO:0043543 | 138 | 0.997 | |
| cellular response to peptide | GO:1901653 | 59 | 0.997 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.997 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.997 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.996 | |
| regulation of intracellular estrogen receptor signaling pathway | GO:0033146 | 13 | 0.996 | |
| stem cell development | GO:0048864 | 69 | 0.996 | Mouse |
| regulation of dna templated transcription in response to stress | GO:0043620 | 18 | 0.996 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 3 | 0.996 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 56 | 0.996 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.996 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.996 | Human |
| cell development | GO:0048468 | 328 | 0.996 | Mouse Worm |
| circadian rhythm | GO:0007623 | 21 | 0.995 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.995 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.995 | |
| regulation of osteoblast differentiation | GO:0045667 | 38 | 0.995 | |
| organ induction | GO:0001759 | 4 | 0.995 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.995 | Mouse |
| lipid metabolic process | GO:0006629 | 381 | 0.995 | |
| regulation of cell development | GO:0060284 | 161 | 0.994 | |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.994 | |
| positive regulation of gluconeogenesis | GO:0045722 | 1 | 0.993 | |
| cytokine production | GO:0001816 | 247 | 0.993 | |
| cell cell signaling | GO:0007267 | 155 | 0.993 | |
| cell fate commitment | GO:0045165 | 27 | 0.993 | |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.993 | |
| protein catabolic process | GO:0030163 | 325 | 0.993 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.992 | |
| tubulin deacetylation | GO:0090042 | 4 | 0.991 | Human |
| positive regulation of myeloid cell differentiation | GO:0045639 | 39 | 0.991 | |
| regulation of cell growth | GO:0001558 | 135 | 0.991 | |
| neurogenesis | GO:0022008 | 169 | 0.990 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.990 | |
| cell projection organization | GO:0030030 | 252 | 0.989 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.989 | |
| embryonic organ development | GO:0048568 | 36 | 0.989 | |
| reproductive process | GO:0022414 | 106 | 0.988 | Worm |
| negative regulation of cell death | GO:0060548 | 345 | 0.988 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.988 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.988 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.987 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.987 | |
| response to lipid | GO:0033993 | 206 | 0.987 | Human |
| regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter | GO:0035947 | 1 | 0.987 | |
| female gamete generation | GO:0007292 | 2 | 0.986 | Worm |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.986 | |
| myoblast fusion | GO:0007520 | 1 | 0.986 | |
| regulation of autophagy | GO:0010506 | 52 | 0.986 | |
| tube development | GO:0035295 | 125 | 0.986 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.985 | |
| chordate embryonic development | GO:0043009 | 34 | 0.985 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.984 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.983 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.981 | |
| androgen receptor signaling pathway | GO:0030521 | 34 | 0.981 | Human |
| response to steroid hormone | GO:0048545 | 80 | 0.981 | Human |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.981 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.980 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.980 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.979 | |
| generation of neurons | GO:0048699 | 152 | 0.979 | |
| n terminal protein amino acid acetylation | GO:0006474 | 10 | 0.979 | |
| response to estradiol | GO:0032355 | 23 | 0.979 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.978 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 9 | 0.977 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.974 | |
| response to peptide hormone | GO:0043434 | 61 | 0.973 | |
| maintenance of location | GO:0051235 | 112 | 0.973 | Worm |
| single organism reproductive process | GO:0044702 | 98 | 0.973 | Worm |
| cellular component morphogenesis | GO:0032989 | 314 | 0.973 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.973 | Rat |
| embryonic camera type eye morphogenesis | GO:0048596 | 2 | 0.972 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.972 | |
| hormone mediated signaling pathway | GO:0009755 | 22 | 0.972 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 48 | 0.972 | |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.972 | Worm |
| dna repair | GO:0006281 | 198 | 0.972 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.971 | |
| positive regulation of autophagy | GO:0010508 | 24 | 0.971 | |
| glycerolipid metabolic process | GO:0046486 | 107 | 0.970 | |
| response to ionizing radiation | GO:0010212 | 65 | 0.970 | |
| positive regulation of viral transcription | GO:0050434 | 13 | 0.969 | Human |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.968 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.968 | |
| regulation of protein import into nucleus | GO:0042306 | 78 | 0.967 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.966 | |
| n terminal peptidyl lysine acetylation | GO:0018076 | 4 | 0.965 | |
| cellular response to lipid | GO:0071396 | 127 | 0.965 | |
| sensory organ development | GO:0007423 | 52 | 0.965 | |
| positive regulation by host of viral transcription | GO:0043923 | 11 | 0.964 | Human |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.964 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.964 | |
| muscle tissue development | GO:0060537 | 62 | 0.963 | |
| positive regulation of chromosome organization | GO:2001252 | 41 | 0.963 | |
| tube morphogenesis | GO:0035239 | 95 | 0.963 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.963 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.962 | Worm |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.960 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.960 | |
| modulation by host of viral transcription | GO:0043921 | 20 | 0.959 | Human |
| glucose metabolic process | GO:0006006 | 45 | 0.958 | |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.958 | |
| positive regulation of protein catabolic process | GO:0045732 | 75 | 0.957 | |
| regulation of transcription by galactose | GO:0000409 | 1 | 0.956 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.956 | |
| viral process | GO:0016032 | 146 | 0.956 | Human |
| lipid biosynthetic process | GO:0008610 | 177 | 0.956 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.955 | |
| regulation of glucocorticoid receptor signaling pathway | GO:2000322 | 2 | 0.955 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.954 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.952 | |
| n terminal protein amino acid modification | GO:0031365 | 13 | 0.952 | |
| stem cell differentiation | GO:0048863 | 93 | 0.951 | Mouse |
| response to radiation | GO:0009314 | 151 | 0.951 | |
| granulocyte differentiation | GO:0030851 | 16 | 0.950 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.950 | |
| insulin receptor signaling pathway | GO:0008286 | 23 | 0.949 | |
| regulation of protein localization | GO:0032880 | 296 | 0.949 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.948 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.948 | |
| chromatin remodeling | GO:0006338 | 55 | 0.947 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.947 | |
| keratinocyte differentiation | GO:0030216 | 36 | 0.946 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 98 | 0.945 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.945 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 8 | 0.945 | |
| endocrine system development | GO:0035270 | 26 | 0.944 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.944 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.942 | |
| regulation of neuron apoptotic process | GO:0043523 | 35 | 0.942 | |
| neural tube formation | GO:0001841 | 3 | 0.942 | |
| glucose homeostasis | GO:0042593 | 31 | 0.941 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 13 | 0.941 | |
| digestive system development | GO:0055123 | 75 | 0.938 | |
| response to nitric oxide | GO:0071731 | 4 | 0.938 | |
| embryonic placenta development | GO:0001892 | 1 | 0.937 | |
| defense response | GO:0006952 | 315 | 0.937 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.937 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.936 | |
| response to estrogen | GO:0043627 | 47 | 0.935 | Human |
| positive regulation of intracellular protein transport | GO:0090316 | 76 | 0.934 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.934 | |
| embryonic organ morphogenesis | GO:0048562 | 24 | 0.933 | |
| dendrite morphogenesis | GO:0048813 | 14 | 0.932 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.928 | Rat |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.927 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 18 | 0.927 | |
| carbon catabolite regulation of transcription | GO:0045990 | 5 | 0.925 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.924 | |
| neuron death | GO:0070997 | 65 | 0.920 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 10 | 0.919 | |
| protein processing | GO:0016485 | 226 | 0.919 | |
| viral gene expression | GO:0019080 | 35 | 0.916 | Human |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 49 | 0.915 | |
| response to bacterium | GO:0009617 | 144 | 0.915 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.915 | |
| regulation of muscle cell differentiation | GO:0051147 | 31 | 0.914 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.913 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 44 | 0.910 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 47 | 0.909 | |
| regulation of muscle organ development | GO:0048634 | 27 | 0.906 | |
| developmental growth | GO:0048589 | 48 | 0.906 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.906 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.905 | |
| urogenital system development | GO:0001655 | 65 | 0.903 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.903 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.902 | |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.902 | |
| aging | GO:0007568 | 66 | 0.900 | Worm |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.899 | |
| erythrocyte differentiation | GO:0030218 | 28 | 0.899 | |
| neuron apoptotic process | GO:0051402 | 39 | 0.898 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.897 | |
| post embryonic development | GO:0009791 | 2 | 0.895 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.893 | |
| positive regulation of transport | GO:0051050 | 336 | 0.892 | |
| lens morphogenesis in camera type eye | GO:0002089 | 2 | 0.889 | |
| regulation of translation | GO:0006417 | 89 | 0.889 | |
| behavior | GO:0007610 | 112 | 0.887 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.887 | |
| gland morphogenesis | GO:0022612 | 8 | 0.886 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.885 | |
| regulation of protein transport | GO:0051223 | 213 | 0.885 | |
| muscle organ development | GO:0007517 | 56 | 0.883 | |
| regeneration | GO:0031099 | 4 | 0.878 | |
| immune system development | GO:0002520 | 195 | 0.878 | |
| muscle cell differentiation | GO:0042692 | 63 | 0.877 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.877 | |
| positive regulation of homeostatic process | GO:0032846 | 47 | 0.877 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.873 | |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.872 | |
| prostate gland development | GO:0030850 | 3 | 0.872 | |
| positive regulation of triglyceride biosynthetic process | GO:0010867 | 4 | 0.871 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.870 | Human |
| mammary gland development | GO:0030879 | 17 | 0.869 | |
| protein import | GO:0017038 | 130 | 0.869 | |
| amine metabolic process | GO:0009308 | 44 | 0.867 | |
| regulation of cellular component size | GO:0032535 | 82 | 0.866 | |
| neuron projection development | GO:0031175 | 106 | 0.864 | |
| sterol transport | GO:0015918 | 39 | 0.864 | |
| homeostasis of number of cells | GO:0048872 | 40 | 0.863 | |
| neuron development | GO:0048666 | 113 | 0.863 | |
| response to inorganic substance | GO:0010035 | 127 | 0.862 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.860 | |
| steroid metabolic process | GO:0008202 | 94 | 0.859 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.858 | |
| corticosteroid receptor signaling pathway | GO:0031958 | 5 | 0.855 | |
| cytokine mediated signaling pathway | GO:0019221 | 109 | 0.853 | |
| regulation of lipid transport by regulation of transcription from rna polymerase ii promoter | GO:0072367 | 4 | 0.848 | |
| peptide transport | GO:0015833 | 74 | 0.846 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.846 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.843 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.842 | Rat |
| rhythmic behavior | GO:0007622 | 2 | 0.839 | |
| positive regulation of neuron death | GO:1901216 | 14 | 0.832 | |
| translation | GO:0006412 | 132 | 0.832 | |
| response to oxidative stress | GO:0006979 | 121 | 0.831 | |
| epidermal cell differentiation | GO:0009913 | 45 | 0.829 | |
| heart development | GO:0007507 | 95 | 0.828 | |
| regulation of fat cell differentiation | GO:0045598 | 23 | 0.828 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.825 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.825 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 17 | 0.823 | |
| negative regulation of smooth muscle cell differentiation | GO:0051151 | 2 | 0.820 | |
| cellular senescence | GO:0090398 | 34 | 0.820 | |
| negative regulation of g0 to g1 transition | GO:0070317 | 2 | 0.819 | |
| regulation of protein localization to nucleus | GO:1900180 | 85 | 0.818 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.809 | |
| embryo development | GO:0009790 | 123 | 0.808 | Worm |
| positive regulation of cytoplasmic transport | GO:1903651 | 82 | 0.797 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 5 | 0.796 | |
| regulation of viral transcription | GO:0046782 | 34 | 0.793 | Human |
| sterol homeostasis | GO:0055092 | 28 | 0.791 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.784 | Worm |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.783 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.782 | Rat |
| steroid biosynthetic process | GO:0006694 | 46 | 0.774 | |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.772 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.770 | |
| epithelium development | GO:0060429 | 227 | 0.768 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 22 | 0.767 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.764 | |
| regulation of cell division | GO:0051302 | 116 | 0.764 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.762 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.760 | |
| negative regulation of developmental growth | GO:0048640 | 10 | 0.755 | |
| leukocyte differentiation | GO:0002521 | 98 | 0.755 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.754 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.754 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.753 | |
| positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | GO:1901522 | 2 | 0.749 | |
| cardiovascular system development | GO:0072358 | 262 | 0.749 | |
| single organism nuclear import | GO:1902593 | 104 | 0.746 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.743 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.742 | |
| positive regulation of lipid metabolic process | GO:0045834 | 50 | 0.741 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.741 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.740 | |
| multicellular organismal reproductive process | GO:0048609 | 40 | 0.739 | Worm |
| somatic muscle development | GO:0007525 | 1 | 0.738 | |
| regulation of glucose metabolic process | GO:0010906 | 28 | 0.736 | |
| cellular polysaccharide metabolic process | GO:0044264 | 27 | 0.734 | |
| defense response to other organism | GO:0098542 | 129 | 0.734 | |
| protein targeting | GO:0006605 | 187 | 0.733 | |
| protein deacylation | GO:0035601 | 39 | 0.733 | Human |
| gland development | GO:0048732 | 48 | 0.733 | |
| positive regulation of epidermal cell differentiation | GO:0045606 | 8 | 0.730 | |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.728 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.728 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.723 | |
| cell aging | GO:0007569 | 52 | 0.723 | |
| negative regulation of phosphatidylinositol 3 kinase signaling | GO:0014067 | 4 | 0.723 | |
| negative regulation of cell fate commitment | GO:0010454 | 3 | 0.715 | |
| autophagy | GO:0006914 | 88 | 0.714 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.714 | |
| regulation of behavior | GO:0050795 | 82 | 0.714 | |
| regulation of defense response to virus by host | GO:0050691 | 22 | 0.713 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.711 | |
| mammary gland morphogenesis | GO:0060443 | 2 | 0.710 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.710 | |
| methylation | GO:0032259 | 106 | 0.708 | |
| negative regulation of stress activated mapk cascade | GO:0032873 | 19 | 0.705 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.703 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.703 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.702 | |
| modulation of transcription in other organism involved in symbiotic interaction | GO:0052312 | 20 | 0.701 | Human |
| myeloid leukocyte differentiation | GO:0002573 | 60 | 0.700 | |
| positive regulation of neurogenesis | GO:0050769 | 49 | 0.700 | |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.700 | |
| smooth muscle cell differentiation | GO:0051145 | 8 | 0.699 | |
| embryonic hemopoiesis | GO:0035162 | 4 | 0.698 | |
| negative regulation of stress activated protein kinase signaling cascade | GO:0070303 | 19 | 0.692 | |
| negative regulation of chromatin silencing | GO:0031936 | 4 | 0.692 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.686 | Human |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.683 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 4 | 0.683 | |
| segmentation | GO:0035282 | 4 | 0.680 | |
| regulation of dna repair | GO:0006282 | 47 | 0.675 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.673 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.673 | Rat |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.663 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 57 | 0.659 | |
| response to reactive oxygen species | GO:0000302 | 61 | 0.655 | |
| regulation of growth | GO:0040008 | 165 | 0.654 | |
| central nervous system development | GO:0007417 | 123 | 0.653 | |
| positive regulation of leukocyte activation | GO:0002696 | 80 | 0.652 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 36 | 0.645 | |
| neutral lipid metabolic process | GO:0006638 | 27 | 0.645 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.644 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.641 | |
| regulation of lipid transport | GO:0032368 | 44 | 0.633 | |
| cholesterol transport | GO:0030301 | 39 | 0.632 | |
| multi organism cellular process | GO:0044764 | 156 | 0.630 | Human |
| negative regulation of cytoplasmic transport | GO:1903650 | 46 | 0.630 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.628 | |
| locomotory behavior | GO:0007626 | 1 | 0.625 | |
| cellular response to extracellular stimulus | GO:0031668 | 72 | 0.620 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 18 | 0.619 | |
| carbohydrate biosynthetic process | GO:0016051 | 42 | 0.619 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.615 | |
| cellular response to starvation | GO:0009267 | 58 | 0.613 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.613 | |
| lipid localization | GO:0010876 | 106 | 0.612 | Worm |
| regulation of cellular protein catabolic process | GO:1903362 | 96 | 0.611 | |
| brain development | GO:0007420 | 97 | 0.608 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 25 | 0.604 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.597 | |
| regulation of transcription by chromatin organization | GO:0034401 | 1 | 0.597 | |
| regulation of dna templated transcription elongation | GO:0032784 | 23 | 0.597 | |
| regulation of binding | GO:0051098 | 111 | 0.596 | |
| positive regulation of epithelial cell differentiation | GO:0030858 | 14 | 0.596 | |
| cellular hormone metabolic process | GO:0034754 | 41 | 0.595 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 27 | 0.592 | |
| kidney development | GO:0001822 | 53 | 0.592 | |
| multicellular organism reproduction | GO:0032504 | 42 | 0.591 | Worm |
| peptidyl serine phosphorylation | GO:0018105 | 101 | 0.588 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 81 | 0.588 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 37 | 0.583 | |
| regulation of epidermis development | GO:0045682 | 19 | 0.581 | |
| striated muscle cell differentiation | GO:0051146 | 43 | 0.578 | |
| regulation of immune response | GO:0050776 | 201 | 0.578 | |
| protein import into nucleus | GO:0006606 | 104 | 0.575 | |
| eye development | GO:0001654 | 42 | 0.570 | |
| cellular response to reactive oxygen species | GO:0034614 | 50 | 0.570 | |
| regulation of neuron death | GO:1901214 | 56 | 0.568 | |
| regulation of interleukin 5 production | GO:0032674 | 6 | 0.568 | |
| cell cycle arrest | GO:0007050 | 71 | 0.565 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.565 | |
| positive regulation of dendrite development | GO:1900006 | 7 | 0.564 | |
| regulation of developmental growth | GO:0048638 | 30 | 0.562 | |
| heart formation | GO:0060914 | 2 | 0.560 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 45 | 0.554 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.554 | |
| ion homeostasis | GO:0050801 | 230 | 0.552 | |
| regulation of smooth muscle cell proliferation | GO:0048660 | 28 | 0.552 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.552 | |
| male sex differentiation | GO:0046661 | 25 | 0.551 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.546 | Human |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.545 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.541 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 13 | 0.539 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.537 | |
| response to other organism | GO:0051707 | 261 | 0.537 | |
| negative regulation of transport | GO:0051051 | 176 | 0.532 | |
| negative regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0017055 | 2 | 0.531 | |
| regulation of neuron projection development | GO:0010975 | 57 | 0.529 | |
| acylglycerol metabolic process | GO:0006639 | 27 | 0.527 | |
| rhythmic process | GO:0048511 | 31 | 0.520 | |
| protein ubiquitination | GO:0016567 | 314 | 0.520 | |
| primary neural tube formation | GO:0014020 | 3 | 0.519 | |
| positive regulation of myeloid cell apoptotic process | GO:0033034 | 2 | 0.517 | |
| regulation of protein targeting | GO:1903533 | 91 | 0.517 | |
| hemopoiesis | GO:0030097 | 180 | 0.517 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.513 | Human |
| regulation of ion homeostasis | GO:2000021 | 73 | 0.513 | |
| dna damage response signal transduction resulting in transcription | GO:0042772 | 12 | 0.512 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.509 | |
| macromolecule methylation | GO:0043414 | 97 | 0.506 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 17 | 0.502 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.493 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.490 | |
| positive regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061419 | 2 | 0.487 | |
| regulation of transcription involved in lymphatic endothelial cell fate commitment | GO:0060849 | 2 | 0.487 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.487 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.487 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 17 | 0.486 | |
| response to virus | GO:0009615 | 126 | 0.486 | |
| innate immune response | GO:0045087 | 178 | 0.485 | |
| endocytosis | GO:0006897 | 159 | 0.485 | |
| muscle cell development | GO:0055001 | 29 | 0.484 | |
| response to drug | GO:0042493 | 81 | 0.482 | |
| triglyceride metabolic process | GO:0006641 | 23 | 0.481 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.479 | Rat |
| regulation of triglyceride metabolic process | GO:0090207 | 11 | 0.475 | |
| histone methylation | GO:0016571 | 60 | 0.474 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.473 | |
| embryonic skeletal system development | GO:0048706 | 13 | 0.473 | |
| regulation of cellular response to insulin stimulus | GO:1900076 | 17 | 0.468 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.467 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 42 | 0.467 | |
| skeletal system morphogenesis | GO:0048705 | 24 | 0.465 | |
